Trinity Biotech plc (NASDAQ: TRIB) (DUBLIN: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will host a conference call to discuss its recent acquisition of bioMerieux’s coagulation division at 11.00am ET (4.00pm BST) today.
